| Tisotumab Vedotin studied in …STUDIED_INderived13 of 13show fewer |
|---|
| → studied in | NCT06952660Phase 4 · recruiting Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer · 13 trials list this drug (4 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06459180Phase 3 · active not recruiting A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20) · 13 trials list this drug (4 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03485209Phase 2 · active not recruiting Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors · 13 trials list this drug (4 active) | — | — | Carcinoma,Colorectal Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03786081Phase 1/Phase 2 · terminated Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer · 13 trials list this drug (4 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07672782Phase 2 · not yet recruiting Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva · 13 trials list this drug (4 active) | — | — | Vulvar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04697628Phase 3 · completed Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer · 13 trials list this drug (4 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05866354Phase 1 · completed To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies · 13 trials list this drug (4 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03438396Phase 2 · completed A Trial of Tisotumab Vedotin in Cervical Cancer · 13 trials list this drug (4 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03657043Phase 2 · completed A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) · 13 trials list this drug (4 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03913741Phase 1/Phase 2 · completed A Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies · 13 trials list this drug (4 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02001623Phase 1/Phase 2 · completed Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors · 13 trials list this drug (4 active) | — | — | Malignant Lung Neoplasm,Head and Neck Squamous Cell Carcinoma,Malignant Bladder Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03245736Phase 2 · completed Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. · 13 trials list this drug (4 active) | — | — | Malignant Lung Neoplasm,Head and Neck Squamous Cell Carcinoma,Malignant Bladder Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02552121Phase 1/Phase 2 · completed Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors · 13 trials list this drug (4 active) | — | — | Malignant Lung Neoplasm,Malignant Bladder Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |